FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289495433> ?p ?o ?g. }

• W2289495433 endingPage "445" @default.
• W2289495433 startingPage "433" @default.
• W2289495433 abstract "The objective of this study was to examine the implication of Y‐box‐binding protein‐1 (YB‐1) for the aggressive phenotypes, prognosis and therapeutic target in pancreatic ductal adenocarcinoma (PDAC). YB‐1 expression in PDAC, pancreatic intraepithelial neoplasia (PanIN) and normal pancreas specimens was evaluated by immunohistochemistry, and its correlation with clinicopathological features was assessed in patients with PDAC. The effects of YB‐1 on proliferation, invasion and expressions of cell cycle‐related proteins and matrix metalloproteinases (MMPs) were analyzed by WST‐8, cell cycle and Matrigel invasion assays, Western blotting and quantitative RT‐PCR in PDAC cells transfected with YB‐1‐siRNAs. To verify the significance of YB‐1 for tumor progression in vivo, the growth and metastasis were monitored after intrasplenic implantation of ex vivo YB‐1 siRNA‐transfected PDAC cells, and YB‐1‐targeting antisense oligonucleotides were intravenously administered in nude mice harboring subcutaneous tumor. The intensity of YB‐1 expression and positivity of nuclear YB‐1 expression were higher in PDAC than PanIN and normal pancreatic tissues. Nuclear YB‐1 expression was significantly associated with dedifferentiation, lymphatic/venous invasion and unfavorable prognosis. YB‐1 knockdown inhibited cell proliferation via cell cycle arrest by S‐phase kinase‐associated protein 2 downregulation and consequent p27 accumulation, and decreased the invasion due to downregulated membranous‐type 2 MMP expression in PDAC cells. Tumor growth and liver metastasis formation were significantly suppressed in nude mice after implantation of YB‐1‐silenced PDAC cells, and the YB‐1 targeting antisense oligonucleotide significantly inhibited the growth of subcutaneous tumors. In conclusion, YB‐1 may be involved in aggressive natures of PDAC and a promising therapeutic target." @default.
• W2289495433 created "2016-06-24" @default.
• W2289495433 creator A5020122344 @default.
• W2289495433 creator A5042141137 @default.
• W2289495433 creator A5042423658 @default.
• W2289495433 creator A5049198126 @default.
• W2289495433 creator A5077236645 @default.
• W2289495433 creator A5077613670 @default.
• W2289495433 creator A5078409741 @default.
• W2289495433 creator A5083003749 @default.
• W2289495433 creator A5091882168 @default.
• W2289495433 date "2016-03-29" @default.
• W2289495433 modified "2023-10-03" @default.
• W2289495433 title "Nuclear expression of <scp>Y</scp> ‐box binding protein‐1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models" @default.
• W2289495433 cites W1493421534 @default.
• W2289495433 cites W1558187819 @default.
• W2289495433 cites W1895463703 @default.
• W2289495433 cites W1918281504 @default.
• W2289495433 cites W1965587103 @default.
• W2289495433 cites W1966506870 @default.
• W2289495433 cites W1974943922 @default.
• W2289495433 cites W1977379410 @default.
• W2289495433 cites W1995333503 @default.
• W2289495433 cites W1996494247 @default.
• W2289495433 cites W1998462518 @default.
• W2289495433 cites W2000258078 @default.
• W2289495433 cites W2003171179 @default.
• W2289495433 cites W2004219778 @default.
• W2289495433 cites W2018314777 @default.
• W2289495433 cites W2022632543 @default.
• W2289495433 cites W2030183122 @default.
• W2289495433 cites W2030902700 @default.
• W2289495433 cites W2031300692 @default.
• W2289495433 cites W2035643172 @default.
• W2289495433 cites W2036915037 @default.
• W2289495433 cites W2041615411 @default.
• W2289495433 cites W2046821312 @default.
• W2289495433 cites W2047534512 @default.
• W2289495433 cites W2050200352 @default.
• W2289495433 cites W2054557456 @default.
• W2289495433 cites W2058863407 @default.
• W2289495433 cites W2071300994 @default.
• W2289495433 cites W2073354583 @default.
• W2289495433 cites W2079152631 @default.
• W2289495433 cites W2080921790 @default.
• W2289495433 cites W2080985235 @default.
• W2289495433 cites W2082246802 @default.
• W2289495433 cites W2088245792 @default.
• W2289495433 cites W2090803746 @default.
• W2289495433 cites W2102051933 @default.
• W2289495433 cites W2105461260 @default.
• W2289495433 cites W2106965899 @default.
• W2289495433 cites W2113604152 @default.
• W2289495433 cites W2114160235 @default.
• W2289495433 cites W2122472408 @default.
• W2289495433 cites W2134885709 @default.
• W2289495433 cites W2136115649 @default.
• W2289495433 cites W2164953703 @default.
• W2289495433 cites W2167100625 @default.
• W2289495433 cites W2168704602 @default.
• W2289495433 cites W4211208840 @default.
• W2289495433 doi "https://doi.org/10.1002/ijc.30075" @default.
• W2289495433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26939718" @default.
• W2289495433 hasPublicationYear "2016" @default.
• W2289495433 type Work @default.
• W2289495433 sameAs 2289495433 @default.
• W2289495433 citedByCount "32" @default.
• W2289495433 countsByYear W22894954332016 @default.
• W2289495433 countsByYear W22894954332017 @default.
• W2289495433 countsByYear W22894954332018 @default.
• W2289495433 countsByYear W22894954332019 @default.
• W2289495433 countsByYear W22894954332020 @default.
• W2289495433 countsByYear W22894954332021 @default.
• W2289495433 countsByYear W22894954332022 @default.
• W2289495433 countsByYear W22894954332023 @default.
• W2289495433 crossrefType "journal-article" @default.
• W2289495433 hasAuthorship W2289495433A5020122344 @default.
• W2289495433 hasAuthorship W2289495433A5042141137 @default.
• W2289495433 hasAuthorship W2289495433A5042423658 @default.
• W2289495433 hasAuthorship W2289495433A5049198126 @default.
• W2289495433 hasAuthorship W2289495433A5077236645 @default.
• W2289495433 hasAuthorship W2289495433A5077613670 @default.
• W2289495433 hasAuthorship W2289495433A5078409741 @default.
• W2289495433 hasAuthorship W2289495433A5083003749 @default.
• W2289495433 hasAuthorship W2289495433A5091882168 @default.
• W2289495433 hasBestOaLocation W22894954331 @default.
• W2289495433 hasConcept C121608353 @default.
• W2289495433 hasConcept C126322002 @default.
• W2289495433 hasConcept C142724271 @default.
• W2289495433 hasConcept C153911025 @default.
• W2289495433 hasConcept C173396325 @default.
• W2289495433 hasConcept C22615655 @default.
• W2289495433 hasConcept C2778900538 @default.
• W2289495433 hasConcept C2779013556 @default.
• W2289495433 hasConcept C2780210213 @default.
• W2289495433 hasConcept C29537977 @default.
• W2289495433 hasConcept C502942594 @default.
• W2289495433 hasConcept C54009773 @default.

• next